NDC 67296-2297

Amlodipine Besylate 10 mg tablet

On the label: RedPharm Drug. Inc.. It's a repackaged product: RedPharm Drug. Inc. rebottles it from Cipla USA., Inc.'s NDC 69097-128.

Where the pills inside were made

Salcette, India · makes it, tests it, packages it and labels it

Problems found, fixed voluntarily Last FDA inspection Jun 21, 2024. 12 inspections on record, 2 with serious problems.

Indore, India · makes it, tests it, packages it and labels it

Serious problems, FDA action Last FDA inspection Feb 17, 2023. 6 inspections on record, 1 with serious problems.

Raigad, India · makes it, tests it, packages it and labels it

Problems found, fixed voluntarily Last FDA inspection Apr 4, 2024. 7 inspections on record.

Bengaluru, India · makes the active ingredient

Problems found, fixed voluntarily Last FDA inspection Nov 13, 2024. 7 inspections on record.

Oct 3, 2018 · Class III · Terminated
Subpotent Drug: One lot of product does not meet the product specification for Assay test at 3 month long term stability condition.
Lots: Lot #: GG80218, Exp. 12/2019

Generic drug: Amlodipine: see every company that makes it
Form: tablet, oral
Strength: 10 mg
Approval: ANDA ANDA077073
On the market since: Sep 26, 2007
Package NDCs: 67296-2297-3
Official label: DailyMed (National Library of Medicine), updated Aug 4, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?